Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report

Venous thromboembolism occurs in 48–200 out of 1,000 patients with brain cancer per year, which is significantly more frequent than in general population.Case report. A female patient had surgical treatment of anaplastic astrocytoma following radiotherapy and chemotherapy (temozolomide, irinotecan,...

Full description

Saved in:
Bibliographic Details
Main Authors: M. G. Pavlova, I. I. Amergulov, N. V. Likhodey, I. A. Kurkina, I. V. Glinkina, O. G. Zheludkova, M. Yu. Gilyarov
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2021-04-01
Series:Сеченовский вестник
Subjects:
Online Access:https://www.sechenovmedj.com/jour/article/view/217
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050678124183552
author M. G. Pavlova
I. I. Amergulov
N. V. Likhodey
I. A. Kurkina
I. V. Glinkina
O. G. Zheludkova
M. Yu. Gilyarov
author_facet M. G. Pavlova
I. I. Amergulov
N. V. Likhodey
I. A. Kurkina
I. V. Glinkina
O. G. Zheludkova
M. Yu. Gilyarov
author_sort M. G. Pavlova
collection DOAJ
description Venous thromboembolism occurs in 48–200 out of 1,000 patients with brain cancer per year, which is significantly more frequent than in general population.Case report. A female patient had surgical treatment of anaplastic astrocytoma following radiotherapy and chemotherapy (temozolomide, irinotecan, bevacizumab) at the age of 17 years old. She also received dexamethasone. At the age of 20 years, she developed cancer recurrence, that required chemotherapy. After chemotherapy had been initiated, the patient developed deep vein thrombosis of the legs. Rivaroxaban 20 mg/d for 2.5 months with the subsequent switch to enoxaparin 60 mg/d showed no recanalization. Enoxaparin dose increasing up to 160 mg/d demonstrated incomplete recanalization, however, superficial venous thrombosis of the legs developed. Combination therapy with enoxaparin plus warfarin resulted in further deep and superficial veins recanalization.Discussion. In cancer-associated venous thromboembolism that is resistant to low molecular weight heparin monotherapy, short-term combination therapy with low molecular weight heparin and vitamin K antagonists can be considered. However, in recurrent cancer standard treatment protocols can be ineffective.
format Article
id doaj-art-0f50c16233b145d286d2920d62d2a9ed
institution DOAJ
issn 2218-7332
2658-3348
language Russian
publishDate 2021-04-01
publisher Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
record_format Article
series Сеченовский вестник
spelling doaj-art-0f50c16233b145d286d2920d62d2a9ed2025-08-20T02:53:22ZrusFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Сеченовский вестник2218-73322658-33482021-04-01121748210.47093/2218-7332.2021.12.1.74-82174Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case reportM. G. Pavlova0I. I. Amergulov1N. V. Likhodey2I. A. Kurkina3I. V. Glinkina4O. G. Zheludkova5M. Yu. Gilyarov6Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Scientific and Practical Center for Specialized Medical Care for Children named after V.F. Voino-YasenetskySechenov First Moscow State Medical University (Sechenov University); City Clinical Hospital № 1 named after N.I. PirogovVenous thromboembolism occurs in 48–200 out of 1,000 patients with brain cancer per year, which is significantly more frequent than in general population.Case report. A female patient had surgical treatment of anaplastic astrocytoma following radiotherapy and chemotherapy (temozolomide, irinotecan, bevacizumab) at the age of 17 years old. She also received dexamethasone. At the age of 20 years, she developed cancer recurrence, that required chemotherapy. After chemotherapy had been initiated, the patient developed deep vein thrombosis of the legs. Rivaroxaban 20 mg/d for 2.5 months with the subsequent switch to enoxaparin 60 mg/d showed no recanalization. Enoxaparin dose increasing up to 160 mg/d demonstrated incomplete recanalization, however, superficial venous thrombosis of the legs developed. Combination therapy with enoxaparin plus warfarin resulted in further deep and superficial veins recanalization.Discussion. In cancer-associated venous thromboembolism that is resistant to low molecular weight heparin monotherapy, short-term combination therapy with low molecular weight heparin and vitamin K antagonists can be considered. However, in recurrent cancer standard treatment protocols can be ineffective.https://www.sechenovmedj.com/jour/article/view/217anaplastic astrocytomarivaroxabanenoxaparinanticoagulantslow molecular weight heparinwarfarinchemoradiation therapydeep vein thrombosis
spellingShingle M. G. Pavlova
I. I. Amergulov
N. V. Likhodey
I. A. Kurkina
I. V. Glinkina
O. G. Zheludkova
M. Yu. Gilyarov
Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
Сеченовский вестник
anaplastic astrocytoma
rivaroxaban
enoxaparin
anticoagulants
low molecular weight heparin
warfarin
chemoradiation therapy
deep vein thrombosis
title Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
title_full Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
title_fullStr Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
title_full_unstemmed Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
title_short Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
title_sort approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma a case report
topic anaplastic astrocytoma
rivaroxaban
enoxaparin
anticoagulants
low molecular weight heparin
warfarin
chemoradiation therapy
deep vein thrombosis
url https://www.sechenovmedj.com/jour/article/view/217
work_keys_str_mv AT mgpavlova approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT iiamergulov approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT nvlikhodey approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT iakurkina approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT ivglinkina approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT ogzheludkova approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport
AT myugilyarov approachesforthepreventionandtreatmentofvenousthromboembolisminapatientwithanaplasticastrocytomaacasereport